The company’s security and inspection systems are primarily designed at its facilities in the United States and internationally in Finland, Malaysia, India, and the United Kingdom. In addition to product design, it provides system integration services to integrate its products into turnkey systems at the customer site. The company is involved, both in the United States and internationally, in various research projects aimed at improving its medical systems and at expanding its product line. The company’s research and development expenses were $49.6 million in 2012. Patents The company holds U.S. and foreign patents relating to various aspects of its security and inspection products, patient monitoring, diagnostic cardiology and anesthesia systems and optoelectronic devices and subsystems. Its patents would expire at various times between 2012 and 2031. Competition The company’s principal competitors in the market for security and inspection products are Smiths Detection; L-3 Communications—Security and Detection Systems division; American Science and Engineering; Morpho Detection; SAIC; CEIA and Nuctech. The company’s principal competitors in the market for patient monitoring, diagnostic cardiology and anesthesia systems are Philips Healthcare; GE Healthcare; Mindray Medical; Mortara Instrument; Dräger Medical; Nihon Kohden; Penlon, and Maquet. History OSI Systems, Inc. was founded in 1987. The company was incorporated in 1987 in California and reincorporated in the state of Delaware in 2010.
osi systems inc (OSIS:NASDAQ GS)
12525 Chadron Avenue
Hawthorne, CA 90250
|American Science & Engineering Inc||$59.63 USD||-0.17|
|Analogic Corp||$79.97 USD||-0.28|
|CTS Corp||$11.75 USD||+0.33|
|First Sensor AG||€8.21 EUR||-0.03|
|Nihon Kohden Corp||¥3,735 JPY||-95.00|
|View Industry Companies|
Sponsored Financial Commentaries
To contact OSI SYSTEMS INC, please visit www.osi-systems.com. Company data is provided by Capital IQ. Please use this form to report any data issues.